Table 2.
Characteristics of the pleural effusion.
| Characteristics | Medical pleuroscopy patients (n = 92) |
|---|---|
| Etiology for pleural effusion | |
| Malignancy | 69 (75) |
| Lung adenocarcinoma | 47 (51.1) |
| Lung large cell carcinoma | 1 (1) |
| Lung squamous cell carcinoma | 2 (2.2) |
| Lymphoma | 3 (3.3) |
| Mesothelioma | 2 (2.2) |
| Nasopharyngeal cancer | 2 (2.2) |
| Breast cancer | 2 (2.2) |
| Thyroid cancer | 2 (2.2) |
| Colon cancer | 2 (2.2) |
| Sarcomatoid carcinoma | 1 (1) |
| Cholangiocarcinoma | 1 (1) |
| Cervix cancer | 1 (1) |
| Urothelial carcinoma | 1 (1) |
| Gastric cancer | 1 (1) |
| Angiosarcoma | 1 (1) |
| Benign | 23 (25) |
| TB | 8 (8.7) |
| Autoimmune related | 2 (2.2) |
| Chronic pleuritic | 13 (14.1) |
| Drainage amount (ml) | 1059 ± 757 |
| Duration of procedure (minutes) | 34.2 ± 8.6 |
| Duration of subsequent chest drainage (days) | 2.6 ± 2.4 |
| Length of stay after procedure (days) | 2.4 ± 2.6 |
| 30 days mortality | 0 |